Current perspectives on CHEK2 mutations in breast cancer
Panagiotis Apostolou, Ioannis Papasotiriou Department of Molecular Medicine, Research Genetic Cancer Centre S.A. (R.G.C.C. S.A.), Florina, Greece Abstract: Checkpoint kinase 2 (CHEK2) is a serine/threonine kinase which is activated upon DNA damage and is implicated in pathways that govern D...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-05-01
|
| Series: | Breast Cancer : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/current-perspectives-on-chek2-mutations-in-breast-cancer-peer-reviewed-article-BCTT |